SOVIPOSTOBART
UNII U1OMP6W1PM

Substance Identification & Data

This profile provides standardized clinical and technical data for Sovipostobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U1OMP6W1PM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2649371-19-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U1OMP6W1PM

CAS Registry Number

2649371-19-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SOVIPOSTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C146765

National Cancer Institute reference terminology for clinical and research data.

INN ID

12568

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sovipostobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOVIPOSTOBART

Common Names & Synonyms

BMS-986249 (ANTI-CTLA-4 PROBODY MAB)

IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL BMS-986249 .GAMMA.1-CHAIN), DISULFIDE WITH PRODOMAIN PEPTIDE (SYNTHETIC MASKING MOIETY AND PROTEASE-CLEAVABLE MOIETY) FUSION PROTEIN HUMAN MONOCLONAL BMS-986249 .KAPPA.-CHAIN, DIMER

IPILIMUMAB PROBODY BMS-986249

MAB HUMAN (IGG1) ANTI P16410 (CTLA4_HUMAN)(BMS-986249)

SOVIPOSTOBART [INN]

External Clinical & Regulatory Resources

Previous UNIIU1O3J18SFL

Next UNIIU1P3GVC56L